Glucose–insulin–potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis
Authors:
- An-Mei ZhangAZAn-Mei Zhang
- Ying-Bin XiaoYXYing-Bin Xiao
- Yu-Guo WengYWYu-Guo Weng
- Roland HetzerRHRoland Hetzer
- 1 July 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 40 (1) , 192-199
Abstract
Glucose-insulin-potassium (GIK) has long been used as adjuvant treatment for patients with serious cardiovascular disease. Although many studies have reported their results based on GIK therapy in the setting of heart surgery, the outcomes remain controversial and inconclusive. The aim of this meta-analysis of randomized controlled trials (RCTs) was to determine the clinical effects of GIK in adult cardiac surgery patients. Electronic databases and manual bibliographical searches were conducted. A meta-analysis of all RCTs comparing GIK with control in heart surgery was performed. Data for all-causes mortality (within 2 months after surgery), perioperative myocardial infarction, postoperative inotropic support, atrial fibrillation, cardiac index, durations of intensive unit care stay and total hospital stay were extracted, and we summarized the combined results of the data of the RCTs as relative risk (RR), with 95% confidence intervals (CIs). A total of 33 RCTs including 2113 patients were assessed in this study. GIK infusion was associated with significantly fewer perioperative myocardial infarctions (RR = 0.63, 95% CI 0.42-0.95), less inotropic support requirement (RR = 0.66, 95% CI 0.45-0.96), better postoperative cardiac index (weighted mean difference (WMD) = 0.43, 95% CI 0.31-0.55), and reduced length of stay in the intensive care unit (WMD = -7.96, 95% CI -13.36 to -2.55). Further analysis showed that diabetic patients were benefited from GIK with glycemic control, but not GIK infusion without glucose control. GIK significantly reduced myocardial injury and improved hemodynamic performance in patients undergoing cardiac surgery. Glycemic control with GIK might be required for cardiac surgery patients with diabetes.Keywords
This publication has 40 references indexed in Scilit:
- Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-AnalysisThe Annals of Thoracic Surgery, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Prebypass glucose-insulin-potassium infusion in elective nondiabetic coronary artery surgery patientsJournal of Cardiothoracic and Vascular Anesthesia, 1992
- Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: A double-blind studyThe Annals of Thoracic Surgery, 1992
- Insulin as a vasodilating agent in the first hour after cardiopulmonary bypassScandinavian Journal of Thoracic and Cardiovascular Surgery, 1989
- Effects of Graded Insulin Infusions on Plasma Levels of Free Fatty Acids, Adrenaline and Noradrenaline Directly After Open Heart SurgeryThe Thoracic and Cardiovascular Surgeon, 1987
- Reduction of Intraoperative Myocardial Infarction by Means of Exogenous Anaerobic Substrate Enhancement: Prospective Randomized StudyThe Annals of Thoracic Surgery, 1978
- Can the Frequency of Myocardial Infarction Be Reduced during Coronary Artery Operations?The Annals of Thoracic Surgery, 1977
- Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarctionThe American Journal of Cardiology, 1962